Noze is a Montreal diagnostics company developing breath-based screening technology that analyzes volatile organic compounds in exhaled breath. The company positions its platform as a digital odor perception system that combines sensor hardware, data processing, and machine learning to identify disease-related scentprints. Its public materials focus on scalable, non-invasive screening for conditions such as infectious disease and cancer.